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Tissue engineering approaches utilize scaffolds with or without cells to reconstruct, repair, 
or regenerate lost tissues. These scaffolds are created using either natural or synthetic biomaterials 
or their composites. Although each of these biomaterials has its own advantages and 
disadvantages, collagen-based scaffolds are a popular choice in tissue engineering because 
collagen is a major protein component of extracellular matrices (ECM). Despite providing the 
favorable biological environment for cells to recreate tissues, collagen-based scaffolds suffer 
limited mechanical properties, mostly due to limitations in laboratory-based fabrication 
methodologies.  
To overcome this and increase a scaffold’s mechanical property, compression molding of 
collagen, which leads to a dense collagen material, was developed; however, it is confined to 
creating thick sheets and films. We therefore aimed to develop a biofabrication method that can 
mold collagen scaffolds into tubular and hollow structures. It is particularly important for 
genitourinary tissue engineering, where tubular and hollow scaffolds are needed for tissue 
reconstruction. 
 We utilized SolidworksTM software to design hollow and tubular molds and 3D print them 
using a biodegradable material. We further devised a biofabrication chamber to produce tubular 
and hollow collagen scaffolds. We also fabricated collagen discs that are potentially usable as a 
patch for partial graft applications and tested their mechanical properties by measuring its breaking 




We plan to devise methods to improve the mechanical strength of collagen, starting with 
various physical and chemical modifications. The next steps involve a current project with the goal 
of developing a urodynamic chamber and a simulation-based software program to evaluate the 
performance of scaffolds under urinary flow conditions. The future steps will be evaluating these 
scaffolds in small animal models to study their in vivo biomechanical performance.  
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CHAPTER 1: INTRODUCTION 
1.1 Bladder Cancer and Current Treatments 
Bladder cancer is the fourth most common cancer in men. It affected about 68,000 adults 
in the United States in 2017, and there are projected to be 81,900 new cases and 17,240 deaths 
from bladder cancer in 2018. [1,2] It most frequently affects older males but can also affect women 
and younger people. It usually starts when the urothelial cells that line the inside of the bladder 
start to grow excessively. However, it can occur in other areas of the urinary tract, such as ureters 
or the urethra. [3] It hinders quality of life and requires extensive diagnosis, treatment, and medical 
care. [4]  
Bladder cancer and other urinary tract defects may require total replacements depending 
on the severity. Reconstructive procedures frequently use gastrointestinal segments, which is not 
ideal for bladder procedures because gastrointestinal tissue absorbs the solutes that bladder tissue 
wants to excrete. This pervasive problem led scientists to research alternative methods for bladder 
repair or replacement. [5] 
 
1.2 Introduction to Urinary Tissue Engineering 
Tissue engineering uses highly porous artificial extracellular matrices, otherwise known as 
scaffolds, to fill tissue voids, provide structural support, and deliver cells and growth factors that 
can form tissues in three dimensions in the body upon transplantation. Biologically active factors 
and DNA are essential in contributing to these objectives. Among the existing possibilities, three-
dimensional (3D) scaffolds have been one of the most effective and analyzed options. The two 
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main uses of scaffolds in tissue engineering are as a cell support device for in vitro seeding and as 
a growth factor/drug delivery device. Many of these scaffolding procedures are often combined to 
increase effectiveness. [6] A couple of the biggest ongoing challenges in tissue engineering are the 
improvements to mechanical strength of scaffolds and interconnection channels that allow cell 
growth on scaffolds. [7] 
Urinary tissue engineering focuses on treatment methods for the bladder, urethra, and 
ureters. In urology, one of the first goals was to create a bladder replacement. The first prototypes 
used synthetic non-biodegradable materials like silicone, rubber, polypropylene, and 
polytetrafluoroethylene. However, they were prone to infection and caused foreign body reactions. 
Present day models emphasize the design of implantable scaffolds to mimic the physiology and 
function of healthy urinary components. Although one of the primary goals remains to create a 
viable bladder replacement, methods are constantly optimized by new findings. Procedures for the 
bladder and tubular scaffolds (e.g. ureters, urethra) follow a general formulation (Figure 1). [8] 
Scientists continue to advance and improve medicine with the growing number of tissue 





Figure 1: General strategy formulation for urinary tissue engineering. The bladder has one 
general route of work that uses cell-seeded scaffolds (a), while tubular scaffolds have several options 
and can be acellular depending on the application (b). [8] 
  
3D printing has been prevalent in medical fields that need unique replacement parts for 
repair, such as ophthalmology and orthopedics. The field is still undergoing rapid progress 
including urology. Furthermore, 3D printing in urology is more complex with focuses on solid and 
hollow viscous organs, such as the bladder, kidney, and ureters. Within urology, there is potential 
for it to grow as a surgical planning and education tool, medical device production method, and 
for the bioengineering of bioactive materials (Figure 2). Significant advancement would allow 
urologists to create viable replacement 3D-printed scaffolds to restore function to a patient’s 




Figure 2: Applications of 3D printing in urology. A 3D model of a prostate tumor from an MRI 
is used for educating and training students for procedures (a). 3D printing can also be used for 
bioengineering of urological components, such as a kidney scaffold (b). Reprinted with permission  
from [10]. © 2018, Springer Nature. 
 
 
1.3 Biomaterials for Urinary Tissue Engineering 
1.3.1 Selection Criteria 
Biomaterials are an integral aspect of tissue engineering. They contribute to a number of 
factors and play an important part in the viability of a scaffold. A biomaterial must be both 
biocompatible and mechanically stable to fit the minimal requirements. The ideal biomaterial for 
bladder and urethral reconstruction should allow for even and constant attachment of mature 
epithelial cell layer on the luminal surface and keep multiple cell layers of smooth muscle cells on 
the outside. [8] 
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Biodegradability is important because the byproduct production of toxic chemicals would 
be harmful to the host. The degradation rate and byproduct concentration within tissues must be 
below the threshold of negative effect to allow for optimal tissue regeneration. Controlling these 
factors mitigates the risk of a foreign body response or inflammation that can occur when 
implanting a scaffold in the body. The degradation rate is also important to the longevity and 
functionality of a scaffold because it can lead to the need for surgical replacement, which can be 
financially and physically taxing. [5] 
The biomaterial of choice should also be able to regulate cell behavior to promote new 
tissue development. This is regulated by microenvironment interactions, mainly with cell-adhesion 
ligands. A scaffold should be able to support cellular activity for multiple cell types. Whether they 
are inherent or incorporated in the biomaterial, cell-adhesion-promoting factors are important to 
possess to control ligand-induced cell receptor signaling processes. An effective biomaterial 
should allow for easy tissue development to restore function to the body and system. [5] 
It must also provide sufficient mechanical strength and prevent premature mechanical 
collapse before new tissue formation in vivo. For the urinary tract, the main forces are urine filling 
and emptying, flow, and storage. Mechanical support for biomaterials must be maintained until 
the tissue has developed enough strength to support itself. [5] If a scaffold is stitched into place, it 
is important to ensure no tearing will occur at any points of stitching. [8]  
There are three general classes of biomaterials for urinary tissue engineering: natural 
biomaterials (e.g. collagen, alginate), synthetic biomaterials (e.g. polyglycolic acid, silicone), and 
acellular tissue matrices (e.g. bladder submucosa, small-intestinal submucosa). [5] Natural and 
synthetic biomaterials are paramount to this project and will therefore be covered. They have been 
frequently explored in other projects and this project covers the potential benefits of both types. 
6 
 
Polymer blends are also important to consider in this case because the benefits of combining 
natural and synthetic biomaterials into a copolymer blend can be very useful for the purposes of 
urinary tissue engineering.  
 
1.3.2 Natural Biomaterials 
Natural biomaterials are naturally occurring materials and contain many inherent proteins 
and factors, which makes them more biocompatible and allows them to support cell adhesion, 
migration, proliferation, and differentiation. They are biodegradable and capable of supporting cell 
growth and tissue remodeling, making them ideal for replacement or restoration of the function 
and structure of damaged organs and tissues. Natural materials do not trigger a serious host 
response, which simplifies the implantation of a scaffold. They are frequently used for nerve, skin, 
cartilage, and bone repair. Of the many options available, alginate, chitin, chitosan, collagen, 
glycosaminoglycans, and starch are the most used natural biomaterials. [5, 7, 11] 
Natural biomaterials are often scrutinized because of several deficiencies. They are subject 
to large batch-to-batch variation, which can limit use for wider applications. Potential impurities 
can cause immunogenicity and risk damaging the host upon implantation of a scaffold. They are 
also mechanically weak, which reduces their viability for in vivo performance. Although there are 
other shortcomings, these are the main points of concern for choosing natural biomaterials for a 




1.3.3 Synthetic Biomaterials 
Synthetic biomaterials are cost-efficient to mass produce and easy to shape to a desired 3D 
shape. Many material properties are easily tunable, which makes them tailorable to specific 
functions. The degradation rate, mechanical properties, microstructure, and porosity are all 
important properties of urinary tissue engineering scaffolds and can be easily controlled. For any 
tissue engineering protocol that requires 3D printing, synthetic biomaterials are an excellent choice 
because of the simplicity of the process. [8, 12] Polyglycolic acid (PGA), polylactic acid (PLA), 
poly(lactic-co-glycolic acid), and poly(ε-caprolactone) are some of the most frequently used 
synthetic biomaterials and are also often used to make 3D scaffolds. [5, 7] 
Synthetic biomaterials are mainly disadvantageous because they are foreign compounds, 
which will trigger a host response. The difference in composition and structure makes them less 
biocompatible and biodegradable. Tissue remodeling is less inducible, which reduces in vivo 
viability. While the mechanical strength can be useful to have for load-bearing applications, it can 
be a hindrance for mechanical compliance with soft tissue or blood vessels. [7] These issues often 
result in the need for synthetic materials to be paired with a natural material for biomedical 
applications. [11] 
 
1.3.4 Polymer Blends 
A polymer blend is a mix of natural and synthetic biomaterials with unique mechanical and 
structural properties. Synthetic biomaterials are easier to use in biomedical applications, but 
natural biomaterials are more essential because of their biocompatibility. To address this problem, 
a blend takes multiple biomaterials to make a compound with improved biocompatibility, 
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degradation, and mechanical properties compared to their individual components. A blend can use 
multiple natural or synthetic types, but the most common blends feature a mix of a natural and 
synthetic biomaterial. [13] 
Blends are used for desired properties and optimizing them for a desired function. The 
tunability of synthetic materials helps to improve the deficiencies of natural materials, while the 
biocompatibility of natural materials makes the application of synthetic materials less worrisome. 
For urinary tissue engineering specifically, there is no biomaterial that can fulfill the criteria 
mentioned before. Natural and synthetic scaffolds have their respective drawbacks, but a blend 
could address and attempt to mitigate those problems. [5,7,12,13]  
 
1.4 Collagen 
1.4.1 Structure  
Collagen is a major protein in the extracellular matrix, and the most abundant protein of 
connective tissue in animals. [11] There are at least 16 types of collagen, with type I being one of 
the most abundant types of collagen in animals and the first to be characterized. Its main purpose 
is to help tissues withstand stretching, which is a shared purpose across all types of collagen. It has 
a right-handed triple helix structure that includes a prolific amount of the amino acids glycine, 
proline, and hydroxyproline (Figure 3a). These amino acids set up the frequently occurring Gly-
Pro-X sequences, where X represents any amino acid. Each of these amino acids has a specific 
function in the collagen structure. Glycine is special because its hydrogen side chain is the only 
side chain that can fit into the center of the triple stranded helix. The hydrogen bonds that link the 
peptide bond amine of glycine with a peptide carbonyl of an adjacent polypeptide help to hold the 
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three chains together (Figure 3b, 3c). Lastly, the angle of the C-N bond between a peptide and 
proline or hydroxyproline allows polypeptide chains to fold into a helix so that three chains can 
twist to form the triple-stranded helix. The peptidyl-proline linkages stabilize the helical structure 
of collagen. [14, 15]  
 
Figure 3: Structure of the collagen triple helix. The helical structure is apparent in the coiling 
carbon (black) chain (a). Nitrogen (red) and oxygen (blue) atoms are exposed on the outsides of the 
chain to promote hydrogen bonding with other collagen chains. The triple helix is shown in 
structural form (b) and separated to show the bonds that hold the strands together (c). Reprinted with 
permission from [15]. © 2009, Annual Reviews. 
 
Collagen chains are first produced as longer precursors with loose ends, known as 
procollagens. Loose ends are cleaved by procollagen proteinases to form individual triple helical 
proteins, otherwise known as tropocollagen. Tropocollagen monomers arrange to form fibrils that 
possess high tensile strength and can be modified easily to support more stress. Fibrillogenesis in 
situ occurs through two stages of self-assembly of microfibrils: nucleation and fiber growth. These 
stages are highlighted by the elongation and stabilization of collagen fibers based on the structure 
of tropocollagen monomers. Lateral interactions pack fibrils side-by-side in parallel bundles and 
promote the formation of fibers and networks found in bone and tissue in vivo (Figure 4). [14, 16] 
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This is an important process in the formation of biological scaffolds, as it helps to stabilize triple 
helices and support stress in three dimensions. [15] 
 
Figure 4: Synthesis of higher order collagen structures. The procollagen triple helix is cleaved 
by proteinases on the N- and C-terminal ends to form a tropocollagen monomer. These self-assemble 
by lateral interactions that pack monomers in a parallel order to form microfibrils, which can be 
cross-linked to form collagen fibers. Reprinted with permission from [15]. © 2009, Annual Reviews. 
 
1.4.2 Biomaterial Application 
Collagen is also a ubiquitous biomaterial that can form compact cross-linked solids or 
lattice gels. It exhibits time-dependent strain, making it a viscoelastic biomaterial. Its 
viscoelasticity is a result of its fibrillar structure. [17, 18] It exhibits minimal inflammatory and 
antigenic responses, and has been approved by the US Food and Drug Administration (FDA) for 
numerous applications. Intermolecular cross-linking reduced the degradation rate by limiting 
enzyme activity. Cross-linking can be accomplished through numerous physical (e.g. ultraviolet 
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radiation) and chemical (e.g. hyaluronic acid) modification techniques. The easiness of 
modification makes collagen an ideal choice for urinary tissue engineering. [5] 
Collagen as a biomaterial has the same limitations as most natural biomaterials. It brings 
the risks of heterogeneity, immunogenicity, and loss of structural integrity during isolation. 
Collagen as a protein possesses good mechanical strength, but as a biomaterial for scaffolds it has  
poor mechanical performance. [7] An effective synthetic source of collagen and collagen-like 
proteins and fibrils has been observed as a potential solution to these problems. However, synthetic 
collagen would be difficult to use because of post-translational modification and the need for 
complex expression systems. [15] 
Collagen is a seamless choice for urinary tissue engineering because of its 
biocompatability. It does not trigger a foreign body response since it is an abundant protein in the 
body. RGD (arginine-glycine-aspartic acid) cell adhesion sequences promote cellular activity and 
help to retain cellular phenotypes and activity for important cells, such as fibroblasts and 
chondrocytes. These sequences are important for urinary tissue engineering because they can help 




CHAPTER 2: BIOFABRICATION OF COLLAGEN-BASED 
SCAFFOLDS FOR URINARY TISSUE ENGINEERING 
2.1 Introduction to Collagen-Based Scaffolds for Urinary Tissue Engineering 
Collagen-based scaffolds have been observed in numerous publications and clinical 
settings. They are already a very intriguing option in regenerative medicine, with numerous 
methods for production and characterization in existence. [19] Collagen is a great biomaterial for 
urinary tissue engineering scaffolds because of its biocompatibility, resistance to shear flow, and 
viscoelasticity that allows for constant stretching and relaxation. [18,20] Not all collagen-based 
scaffolds have performed well, and not all well-performing scaffolds have made their way to 
clinical implementation. However, the material properties and flexibility for modification make 
collagen a popular choice for the fabrication of a clinically successful scaffold for urinary tissue 
engineering. [21] 
Collagen-glycosaminoglycan scaffolds (CGSs) promote partial organ regeneration due to 
their biological activity that blocks the healing response. This occurs from the binding of 
contractile fibroblasts through integrin-ligand binding, which blocks the generation of 
macroscopic contractile forces normally deployed to contract wounds in injured organs. Pore size 
is critical to the surface cell receptor ligand density. CGSs have been used for regeneration of skin, 
adult organs, and limb paralysis due to trauma. [19] In this case, collagen after chemical 
modification with a natural biomaterial created an effective biomaterial for partial organ 
regeneration. 
Another reported use of collagen-based scaffolds from Atala et al. tested cell-seeded 
collagen and polyglycolic acid-collagen (PGA-collagen) scaffolds for bladder replacement 
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(Figure 5). Patients treated with PGA-collagen scaffolds and omental coverage showed increased 
compliance, decreased end-filling pressures, increased capacities, and longer dry periods over 
time. These positive results affirmed the improvement of the engineered bladder over time to better 
mirror the environment. [5] This example shows the effectiveness of collagen after chemical 
modification with a synthetic biomaterial. 
 
Figure 5: Construction and clinical use of a PGA-collagen scaffold. The cell-seeded scaffold is 
shown before implementation (A), surgically connected to the native bladder (B), and covered with 
fibrin glue and omentum (C). Reprinted with permission from [5]. © 2011, Oxford University Press. 
 
2.2 Design Consideration for Urinary Tissue Engineering Scaffolds 
There are several key factors to consider when designing urinary tissue engineering 
scaffolds. One critical requirement is that the scaffold must be able to endure fluid pressure and 
allow lumen expansion with minimal change in fluid pressure. Of the factors that can affect burst 
pressure, material and wall thickness are a couple of the most important ones. Scaffolds also 
require high porosity and a high surface area to volume ratio. [5] These factors are easily 
manipulatable when using a 3D-printed mold because of the liberty in biomaterial choice and 
scaffold design. [20] 
Material choice is critical because it requires consideration in multiple areas and affects 
downstream factors. Strength is crucial to the functional aspects and preventing the scaffold from 
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rupturing after implantation. Biocompatibility is just as important because of the cell seeding 
viability and foreign body response. Natural biomaterials are reasonable choices because of their 
biocompatibility and biodegradability, but mechanical strength is often lacking. Synthetic 
biomaterials share the opposite problem, as they possess the necessary strength but raise questions 
about biocompatibilty. As covered before, a blend may be the best answer to engineer a material 
that can endure high pressure and reduce the host response. [7, 13] 
These primary considerations were applied to a computer-aided design (CAD) model of a 
bladder mold using SolidWorks™ (Figure 6). Micropores were sized at 150 µm and separated 
diameter-to-diameter by 250 µm. The wall thickness was set at 0.15 cm. The radii of the balloon 
section were set at 1.27 cm (0.5 in) and 1.91 cm (0.75 in). The tube length was set at 2.54 cm (1 
in) and the outer radius was set at 0.5 cm. This design is highlighted by the micropores that are 
used to vacuum excess fluid during scaffold fabrication and improve the scaffold porosity, as well 






Figure 6: CAD drawing and 3D print of bladder-shaped mold. Dimensions for the balloon section (a), 
tube section (b), and outer radius (c) are shown. CAD design was performed in SolidWorks™. The 
microporous structure enables the vacuuming of excess solution and compression of collagen against the 
mold to form the desired shape. A biocompatible material (MED 610) was used to print the mold (d). 
 
We elected to use collagen for the fabrication of scaffolds and preliminary testing. Collagen 
would not elicit a foreign body response and would provide intrinsic proteins. The primary concern 
therefore shifted from an equal weight between mechanical strength and host response to a sole 
focus on the mechanical strength.  Results from mechanical tests would show the necessity of 
modification to improve the mechanical strength of collagen. We later conducted experiments to 




2.3 Fabrication of Bladder-Like and Ureter-Like Scaffolds 
There are various methods for fabricating tissue engineering scaffolds. In the past, we were 
able to produce tubular and sac-like collagen scaffolds following a method based on the work 
mentioned in Singh et al (Figure 7). This version does not use a heated mold, but instead uses a 
3D-printed mold that collagen compresses against after fibrogenesis, all while excess solution is 
removed by vacuum. It is a combination of similar techniques used in vacuum thermoforming and 
stretch-blow molding. Collagen fibrogenesis occurs within the balloon and a vacuum pulls the 
fibers towards a porous mold (vacuum thermoforming) under the contractile pressure of the 
balloon (opposite of stretch-blow molding). The fabrication of these scaffolds is dependent on the 
support provided by the balloon and the internal porous mold that removes excess solution and 





Figure 7: Biomanufacturing of tubular and sac-like collagen scaffolds. Collagen undergoes 
fibrogenesis in the volume it occupies between the balloon and the mold. Afterwards, collagen 
compresses against the mold as excess solution is vacuumed out. A schematic of tubular (A) and 
partial/full sac-like (B) scaffolds displays the process, while the results for the tubular (C) and sac-
like (D) scaffolds shows fabrication of the respective shape. [20] 
 
Molds were designed in SolidWorks™ and fabricated by 3D printing. Desired shape, wall 
thickness, and porosity were considered in the building and designing of CAD models (Figure 6). 
The 3D Print Lab at the Carnegie Center for Surgical Innovation printed CAD designs using the 
respective files. A biocompatible material, MED 610, was used for these molds to mitigate the 
occurrence of a synthetic mold affecting the properties of collagen scaffolds fabricated using one 
of the molds. We were able to produce bladder-like and tubular scaffolds using older molds 
(Figure 8). Surface area calculations showed that the latest rendition of the bladder mold would 
require a lot of collagen solution to produce a scaffold. We were therefore unable to produce a 
scaffold due to our limited supply of collagen and its financial constraints. The protocol for 
fabrication of tubular and bladder-like scaffolds would follow the procedures from previous 
experiments conducted by Singh et al, which are like the steps mentioned earlier regarding vacuum 




Figure 8: Collagen scaffolds produced via compression molding. Tubular (a) and bladder-like 




CHAPTER 3: MECHANICAL EVALUATION OF COLLAGEN AS 
A BIOMATERIAL FOR URINARY TISSUE ENGINEERING 
3.1 Introduction 
The mechanical properties of biomaterials are pivotal in their ability to function as tissue 
engineering scaffolds. If a biomaterial is not strong enough to withstand certain conditions, then 
the scaffold will break. While there are other critical factors to consider, such as the foreign body 
response to a material, the mechanical strength is a primary concern because it determines how 
sustainable a scaffold produced from a specific biomaterial can be. Other critical steps such as 
cellular activity and tissue regeneration cannot be accomplished if the scaffold cannot withstand 
fluid pressure. 
We looked to determine the mechanical strength of collagen fabricated by our method of 
compression molding. We designed different experiments based on the conditions we believed to 
be important for a urinary scaffold. Standard tensile tests would give stress/strain profiles and help 
to determine basic mechanical properties. While the pure strength is important, a bladder will 
frequently expand and restore its shape. Thus, we deemed that in addition to evaluating the pure 
strength of collagen, we would also evaluate the stress and strain profile through a hysteresis loop. 
We also proposed a suture test, where a sample would be sutured on each end and stretched until 
its breaking point. These tests would help to observe the degree to which collagen retained its 
mechanical properties. 
The mechanical analysis is consistent with our prior work and builds off it. Singh et al. 
observed the mechanical strength of tubular collagen scaffolds produced from a similar 
biofabrication chamber by performing standard tensile tests. In our proposed tests, we planned to 
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test the mechanical strength of collagen strips cut from collagen discs from the designed 
biofabrication chamber. In addition, the hysteresis and suture tests will give different points of 
evaluation for collagen. 
 
3.2 Materials and Methods 
3.2.1 Collagen Disc Preparation 
The main part of the setup for the collagen disc included two molds held and separated by 
about 3 cm in a Findom finger condom. Each mold had a microporous disc inserted for filtering 
out excess fluid while keeping collagen entrapped. Luer locks were used to add and remove 
solution, and to prevent solution from escaping during fibrogenesis (Figure 9a). The locks inserted 
into the body were used for adding and removing solutions with a syringe, and the ones attached 
at the top and bottom were used for removing solution through a self-controlled vacuum. A round 





Figure 9: Setup for making a collagen disc. A closer view displays the main section of the setup, with 
arrows showing directions of moving components (a). A wider view of the setup shows all the components 
(b). Collagen solution is added through the Luer lock on the side of the upper mold. It undergoes 
fibrogenesis while encased within the balloon between the two molds. The vacuum runs through the top 
and bottom Luer locks and vacuums excess solution to a round-bottom flask using a double trap vacuum 
setup. When the balloon attained an hourglass shape, the top mold was brought down until the sides were 
parallel. 
 
Compressed collagen discs were made with a mix of collagen (native collagen, bovine 
dermis 5 mg/mL) with Dulbecco’s Modified Eagle’s Medium (DMEM, 1X), fetal bovine serum 
(FBS), and HEPES buffer (1M). A ratio of 88 vol% DMEM, 10 vol% FBS, and 2 vol% HEPES 
was used to make neutralizing solution for the same amount of collagen. For 5 mL discs, 6 mL of 
collagen was mixed with the neutralizing solution mix of 5.28 mL DMEM, 0.6 mL FBS, and 0.12 
mL HEPES. For 10 mL discs, 11 mL of collagen was mixed with the neutralizing solution mix of 
9.7 mL DMEM, 1.1 mL FBS, and 0.22 mL HEPES. The neutralizing solution mix was added to 
the collagen with both solutions at 4℃ and mixed using a motorized pipette. The mixed collagen 
solution was transferred into the apparatus using a 30 mL syringe. After letting fibrogenesis 
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complete while leaving the apparatus untouched for an hour, excess fluid was vacuumed by 
pressing the top mold down when the curvature of the balloon condensed into an hourglass shape.  
Collagen discs were removed from the setup and dried briefly. They were transferred in 
petri dishes to an incubator to vitrify for 20 hours, which helped to further remove excess solution. 
A fabricated collagen disc before and after vitrification is distinguishable by the pink coloring 
apparent before vitrification, which comes from the DMEM used for the neutralizing solution 
(Figure 10). Vitrified collagen discs were sealed in small petri dishes and stored in 4℃. 
  
Figure 10: Collagen discs fabricated from the biofabrication chamber. Collagen discs 
immediately after completion of biaxial compression by vacuum showed slight pink coloring due 
to the use of DMEM (a). Collagen disc after 20 hours of vitrification were colorless due to the 
removal of water (b). 
 
 
3.2.2 Mechanical Testing Experiments 
Prior to testing, collagen discs were removed from 4℃ and cut into rectangular strips using 
a razor blade. Collagen strips remained hydrated in phosphate-buffered saline (PBS) at room 
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temperature to prepare them for testing. Before putting in the testing apparatus, collagen strips 
were blot-dried with a Kimwipe and cut into small rectangular strips if needed.  
For tensile tests, each sample was put in a paper apparatus that was gripped at each end 
using tensile grips (Figure 11). Small paper strips with Krazy Glue were used to hold a sample at 
both ends. The length, width, and thickness were recorded prior to testing. The length was 
considered as the distance between both ends of collagen in the paper apparatus. Immediately prior 
to gripping the apparatus, the sample was blotted with PBS. Samples were stretched at various 
rates from 1-2 mm/min that were established as inputs before the start of a run. 
  
Figure 11: Paper apparatus for holding collagen during tensile and hysteresis tests. Paper ends 
were held by tensile grips as the upper end was stretched out. Length measurements were recorded 
prior to making cutouts on the sides to ensure a straight measurement. The sides are cut out in this 
figure, but during experiments they were cut immediately prior to the start of a run to keep a sample 
as straight as possible. 
 
For suture tests, samples were threaded and knotted on each end with a suture string. Each 
knot was held by a tensile grip. The length, considered as the distance between both sutures, was 
recorded prior to testing. Samples were stretched at various rates from 1-2 mm/min. 
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Hysteresis testing was performed for vitrified collagen, which had a lower water content 
and improved porosity. Vitrification was performed to crosslink collagen. The setup was the same 
as that used for the tensile tests. For this experiment, the sample went through three cycles of 
stretching and restoring. The max length was set at 30% of the strip length, and the elongation rate 
was set at 10% of the max length per minute.  
Pericardium, a product produced by Coloplast, was tested and compared to collagen as a 
standard because of its collagen composition. Before testing, it was cut into strips and stored in 
PBS to maintain freshness. We performed tensile and suture tests to compare the breaking point 
from each test with that of collagen. The methods for testing pericardium followed the same 
procedure as the collagen testing. 
All tests were performed using the MTS CriterionTM Model 43. A 5N load cell was used to 
record measurements. For tensile and hysteresis tests, the width, thickness, initial length, and 
elongation rate were inputted before starting a run. For suture tests, only the initial length and 
elongation rate were inputted before starting a run. The initial length was measured as the distance 
between the ends where a strip was held. Data recording concluded when a sample broke or the 
load (force) exceeded the limit of the load cell. All data was transferred to and analyzed in 
Microsoft Excel and GraphPad Prism. 
 
3.3 Results and Discussion 
3.3.1 Stress and Strain Calculation 
The main objective of these experiments was to evaluate and compare the mechanical 
properties of compressed collagen to the mechanical properties of the bladder of several other 
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species, but mainly the human bladder. The experimental data obtained would give the results 
needed to make these comparisons and note the necessary improvements and limitations. 
For tensile and hysteresis test results, samples were evaluated based on their stress-strain 
profile. The stress, given in megapascals (MPa), was calculated by using the formula shown. 
𝑆𝑡𝑟𝑒𝑠𝑠 (𝑀𝑃𝑎) =
𝐿𝑜𝑎𝑑 (𝑁)
𝐶𝑟𝑜𝑠𝑠 𝑠𝑒𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝑎𝑟𝑒𝑎 (𝑚𝑚2)
=
𝐿𝑜𝑎𝑑
𝑊𝑖𝑑𝑡ℎ (𝑚𝑚) ∗ 𝑇ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 (𝑚𝑚)
 
The strain, defined as the percentage of how much a sample stretched out from its initial length, 





The breaking point of a sample was determined by the ultimate tensile strength (UTS) and ultimate 
tensile strain, which were defined by the maximum values of stress and strain recorded before a 
sample completely broke or a run ended. 
For suture tests, samples were evaluated based on their load-strain profile. The load was 
given in gram-force (gf). The cross-sectional area was not necessary to account for because of the 
expansion and offsetting due to suturing. The breaking point was determined by the ultimate 
strength and ultimate suture strain, defined as the peak values of load and strain before a sample 
broke or a run ended. 
 
3.3.2 Mechanical Strength of Collagen 
Unmodified collagen displayed qualities of a semi-elastic biomaterial. It exhibited a J-
shaped curve in its stress-strain profile from the tensile tests (Figure 12). J-shaped curves show 
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that initial stretching is easier on a material and requires less stress than longer extensions do. 
Biological soft tissues commonly exhibit a J-shaped stress-strain curve. As collagen is stretched, 
fibers straighten and align to provide more strength. Fibers can endure the magnitude of the load 
at lower strain but not all can endure higher strain. [22] 
 The tensile curves show that both collagen and pericardium can endure higher forces but 
are more brittle. Vitrification resulted in a noticeable improvement in the UTS and ultimate strain, 
which were also slightly than that of pericardium. Both versions of collagen and pericardium 
endured a constant increase in stress from initial stretching to the breaking point. In contrast, the 
rabbit ureter is weaker but more flexible as shown in its ability to stretch past 100%. The stress-
strain curve resembles a J-shape much more, as the rabbit ureter did not exhibit much stress until 
around 100% strain. Vitrified collagen is the most suitable choice of the biomaterials tested, but 
the elasticity would need to be improved for it to be more viable. 
 The suture curves show more promise in the viability of collagen, specifically vitrified 
collagen. While unmodified collagen was weak and brittle, vitrification improved the suture 
retention strength and strain. EDC/NHS crosslinking did not show any beneficial effects, as it 
decreased the strain of collagen while providing a minimal improvement to the suture strength. 
Pericardium was much stronger than any other material tested and shared a similar ultimate strain 
with the rabbit ureter. Based on the suture profiles, vitrified collagen was the most like the rabbit 






Figure 12: Tensile and suture profiles of materials. Tensile profiles display the standard stress-
strain curves up to the breaking points (a). Suture profiles display the mechanical strength and 
breaking tendencies of materials (b, c). Based on the suture tests, Vitrified collagen shared the most 
resemblance with the rabbit ureter. None of the tensile curves were like that of the rabbit ureter, 
although vitrified collagen possessed the highest UTS and ultimate strain. Each material was tested 




The hysteresis experiment required a sample that was unlikely to break during several 
cycles of stretching and restoring. We chose not to test unmodified collagen since the tensile results 
showed that it only held to around 60% strain. We used vitrified collagen because its lower water 
content and improved porosity made it more viable. The max length was set at 25% to be safe and 
ensure that the sample would not tear in the middle of the experiment. For pericardium, the max 
length was set at 33%. The max length for the rabbit ureter was set at 100%.  
The results verified the viscoelastic properties of collagen with multiple time-dependent 
strain cycles (Figure 13a). A purely elastic material will have complete reversibility, but a 
viscoelastic material is not completely reversible. Viscoelastic materials exhibit a time delay in 
moderate resistance to shear flow and absorb energy. The area between the stretching and relaxing 
curves is known as hysteresis. [23]  
Vitrified collagen was able to endure three cycles of stress-strain hysteresis. The low values 
in stress are a result of the low strain percentage used. These experiments served to observe the 
behavior of materials rather than evaluate their ultimate strength values. All three materials tested 
exhibited similar characteristics in that the second and third cycles of hysteresis were nearly 
identical. The first cycle is typically different as it is when the material is initially stretched out, 






Figure 13: Hysteresis profiles of various materials. Vitrified collagen (a), pericardium (b), and 
rabbit ureter (c) were stretched to various strain percentages in three cycles of stress-strain 
hysteresis. Each cycle displays a J-shape curve and loss of energy during relaxation, displaying the 





3.3.3 Use of Pericardium as a Reference 
Pericardium Tutoplast-processed allograft tissue is a commercially available product from 
Coloplast. It is a decellularized tissue from bovine pericardium and contains collagen. Multi-
directional fibers allow the membrane to conform to any shape. It was compared alongside the 
experimental collagen because it is an industrial biological tissue. Ideally, our method of 
fabricating collagen scaffolds would produce a variation of collagen as strong as a commercially 
produced product. [24]  
In the tensile and suture tests, pericardium exhibited a J-shape stress-strain curve. Its tensile 
profile is not indicative of its UTS because it typically exerted a force that was greater than the 
maximum capacity of the load cell (Figure 12a). Its tensile behavior was still like that of collagen, 
as stress started to increase almost immediately and noticeably with increased strain. Pericardium 
also exhibited a higher suture retention strength than collagen (Figure 12b). Its ultimate strength 
was significantly greater than the ultimate strength of collagen.  
Overall, its mechanical properties were much stronger than that of collagen. As a 
commercial product, it was unsurprising to see it perform well mechanically. The multi-directional 
fibers are one of many potential factors that contribute to its mechanical strength. Processing 
techniques were also likely contributors to its strength. The staggering difference in strength 
showed more about the deficiencies of our fabricated collagen. 
 
3.3.4 Mechanical Limitations 
Collagen lacked the mechanical strength that other samples possessed. It did not perform 
near the level of pericardium and could not achieve 100% tensile strain. Comparisons between the 
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UTS and ultimate tensile strain of compressed collagen with that of the human, pig, and rat bladder 
affirm that collagen would not be mechanically viable for any of these animals (Table 1). Collagen 
barely managed to perform as well as the human bladder. Its UTS and ultimate tensile strain fell 
short to that of the pig and rat bladder. The ultimate strain did not match that for either of the three 
animal bladders.  





U Tensile Strain 
[mm/mm] 
Rat bladder 0.72 ± 0.21 2.03 ± 0.44 
Pig bladder 0.32 ± 0.10 1.66 ± 0.31 
Human bladder 0.27 ± 0.14 0.69 ± 0.17 
 
Mechanical strength is a key checkpoint on the path to clinical viability for tissue 
engineered scaffolds. This method for biofabrication of collagen would not be suitable for the 
creation of an artificial bladder for either of these mammals because of its lacking mechanical 
strength. Modifying collagen to increase the mechanical strength is important to proceed with in 
vivo testing and future directions. An improved version of collagen could potentially be a suitable 
biomaterial choice for a human bladder.  
The collagen hysteresis experiment performed utilized vitrified collagen. The tensile 
results showed that unmodified collagen would not have been sufficient for a hysteresis test and a 
modified version of collagen would be necessary. We used our results to observe the similarities 
and differences between vitrified collagen and cross-linked collagen. A hysteresis experiment with 
unmodified collagen would have been performed at low strain and most likely inconclusive to the 
overall performance. Nevertheless, it would be good to observe the stress-strain hysteresis profile 
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of unmodified collagen to observe if it still exhibits viscoelasticity and compare it with other 
modified versions of collagen.  
 
3.3.5 Potential Challenges 
Although the results may infer that collagen is slightly short of being a mechanically viable 
biomaterial for urinary tissue engineering scaffolds, it is important to note some of the limitations 
of collagen-based scaffolds from this study and in general. The biofabrication process devised is 
advantageous because of the easiness of manipulation of 3D shape, porosity, and thickness. 
However, the results showed that this method does not provide collagen with the mechanical 
strength necessary to be used for urinary tissue engineering scaffolds.  
On top of the lacking mechanical strength, the cost and time investment to produce each 
scaffold may make this process less effective. Fabricating a collagen scaffold can require a copious 
amount of collagen, which we experienced with our updated bladder mold. Even if this 
biofabrication process is quicker than other methods, more thorough analysis of these areas would 
be needed to make a viable comparison with other processing techniques. The degradation rate of 
collagen is also of concern, since natural biomaterials are known to degrade faster than synthetic 
biomaterials. The best way to observe the degradation rate would be through in vivo studies. 
Biomaterials for tissue engineering in urology have been gaining traction for some time. 
While they were first used to repair urinary tract segments, they are now being experimented to 
create 3D scaffolds that can serve as total replacements for patients with deficiencies in their 
urinary tract. However, one of the biggest problems holding back all types of scaffolds from the 
next step is the evidence that they can match current urological tissue replacement therapies. Some 
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significant areas of concern that are hindering the progression of 3D scaffolds are cost, efficiency, 
manufacturing, and regulation. The biggest concern is the proof of in vivo function and viability. 
Larger genitourinary defects require complex networks that biomaterials have not been shown to 
have. The urinary system has many other factors that should also be considered, including 
surrounding mechanical forces, pH, cytotoxic agents, signaling agents, and oxygen levels. The 
effect of these concerns on the mechanical properties of a replacement scaffold would have to be 
observed and addressed to evaluate the mechanical viability of a biomaterial for urinary tissue 
engineering. Even if some factors have a minimal to no effect on mechanical properties, they are 
important to address to reach the ultimate goal of creating a 3D scaffold that can be applied 
clinically. [21] 
 
3.3.6 Alternatives and Potential Improvements 
In consistency with earlier statements, a stronger material is safer and can handle extreme 
cases better. Modified collagen could provide the extra strength needed to validate collagen as a 
viable biomaterial for urinary tissue engineering. Singh et al. modified collagen by adding 
hyaluronic acid, which resulted in improved strength. [20] We have tested some modifications that 
we cannot disclose currently, but our results with these experiments have verified that chemical 
modification is a solution to improving the weak inherent mechanical strength of collagen. 
The bladder can stretch in multiple directions, meaning that multidirectional force is a 
factor in the mechanical analysis. Therefore, a biomaterial should not be completely evaluated 
based on its uniaxial stretching. Biaxial stress-strain experiments would give a better reflection of 
a biomaterial for urinary tissue engineering. Collagen discs are compressed biaxially during 
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fabrication, but we plan to perform biaxial mechanical tests for future samples to observe if there 
is a difference in mechanical strength between different axes. 
The testing conditions for runs that required more time were not the most ideal because 
samples dehydrated and dried up with time, which affected the material properties. This problem 
was most prevalent for the hysteresis test, which took about an hour, but could have been a factor 
in the longer suture and tensile tests. Stretching strips at a rate based on length rather than a 
constant value may produce more consistent results and will be considered, as larger or thinner 
strips may dry out quicker than smaller or thicker ones. Furthermore, the apparatus for holding 
collagen could be improved to reduce the risk of slippage during a run. Dahms et al. used a 
‘sandpaper sandwich’ to improve grip, which we plan to implement in future mechanical tests to 
observe the effectiveness of sandpaper. [25] 
 
Figure 14: Dahms et al. schematic of the ‘sandpaper sandwich’ used for tensile testing. 
Sandpaper helps to prevent slippage of the apparatus from the grips during mechanical testing. We 




Our sample size was less than ideal for nearly every experiment, with the potential 
exception of the collagen suture tests. Due to financial constraints, we limited our experiments to 
fewer samples. Furthermore, we had to ration collagen discs and solution for other experiments, 
some of which were unrelated and therefore not mentioned. Production of the sac-like and tubular 
scaffolds requires a larger volume of collagen because they are larger than discs. With more 




CHAPTER 4: CONCLUSION AND FUTURE OUTLOOK 
4.1 Conclusion 
Urinary tissue engineering methods have sought to find a way to produce a clinically viable 
scaffold. One of the key factors in engineering of a scaffold is finding a biomaterial suitable for 
the conditions of the urinary system. Fabricated scaffolds must be able to resist breakage by 
pressure from stretching. Collagen has many desirable qualities of a biomaterial for urinary tissue 
engineering, as it is a natural biomaterial and is biocompatible. Further tuning of mechanical 
properties is required, so we proposed testing whether collagen fabricated by our biofabrication 
chamber is mechanically viable to be used for urinary tissue engineering scaffolds. 
Our method of compression molding and fibrogenesis allowed us to successfully create 
microporous collagen scaffolds and shape them as bladder-like and tubular scaffolds. Fabrication 
of these scaffolds requires a good amount of collagen solution. Furthermore, the viscoelastic 
properties of collagen were confirmed by its endurance and the stress-strain curves from the 
hysteresis test of vitrified collagen. However, collagen produced by the compression molding 
method did not have the sufficient mechanical strength to be used as a biomaterial for urinary 
tissue engineering scaffolds. Its ultimate strength and stress from both the tensile and suture tests 
barely matched or was slightly less than the standards for parts of the human urinary system.  
Various routes can be taken to improve the mechanical strength of collagen. Structural 
modification is a frequent solution to improving and modifying specific qualities of a biomaterial. 
There are many approaches to modification, whether performed through changing the solvent or 
administering additional treatment. We believe that structural modification can address this issue 
and is relatively easy to perform. We have already experimented with various modifications to 
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improve the strength while trying to maintain the biocompatibility of collagen and are still in the 
process of weighing the options. 
 
4.2 Future Outlook 
A primary concern emphasized from the results is the lacking mechanical strength of 
compressed collagen. Since emphasis was placed on making a mechanically compliant 
biomaterial, this goal should be completed before moving onto further steps. Physical and chemical 
modifications are some of the simplest and more straightforward methods to address this issue. 
Many physical and chemical modifications have already been considered and experimented with. 
The goal here is to find the modification that will improve mechanical strength the most while 
retaining optimal biocompatibility. 
Following the confirmation of the mechanical viability of a biomaterial, one of the next 
steps would be to evaluate the performance of compressed collagen scaffolds under urinary flow 
conditions. To do this, we plan to create a urodynamic flow chamber, which would hold a scaffold 
and power urinary flow through a chamber. By simulating urinary flow through the chamber, we 
can use data acquisition to observe pressure values along a scaffold. We would evaluate the 
performance of both bladder-shaped and tubular scaffolds to determine if certain areas of a 
particular scaffold are weaker and require more attention. 
In future work, we plan to evaluate cell-seeded collagen scaffolds in small animal models 
to study their in vivo biomechanical performance. Small animal models would also be used to 
observe scaffold ability to support cellular activity. We hope to eventually utilize our 
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biofabrication method to create collagen scaffolds for other purposes, such as the small intestine, 
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